Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Researchers solve key part of muscle regeneration mystery

Working with mice, Johns Hopkins researchers have solved a key part of a muscle regeneration mystery plaguing scientists for years, adding strong support to the theory that muscle mass can be built without a complete, fully functional supply of muscle stem cells.

28 Sep 2012

Efavirenz drug may play a key role in brain damage

The way the body metabolizes a commonly prescribed anti-retroviral drug that is used long term by patients infected with HIV may contribute to cognitive impairment by damaging nerve cells, a new Johns Hopkins research suggests.

28 Sep 2012

Methodist Health System celebrates latest expansion in North Texas

Today Methodist Health System celebrated its latest expansion in North Texas during a groundbreaking ceremony for the Methodist Richardson Medical Center – Bush/Renner hospital.

28 Sep 2012

Canadian Stroke Congress to take place from Sept. 30 to Oct. 2

Researchers from across Canada and around the world are gathering in Calgary for the largest-ever Canadian Stroke Congress, drawing much-needed attention to one of society's leading health issues. The Canadian Stroke Congress runs from Sept. 30 to Oct. 2 at the Calgary Telus Convention Centre.

28 Sep 2012

Warfarin therapy should not be stopped completely after GI bleeding

The decision to not resume warfarin therapy following a gastrointestinal bleeding event is linked to an increased risk for thrombosis and mortality, researchers suggest.

27 Sep 2012

CJD presents major diagnostic problems

Most patients with sporadic Creutzfeldt-Jakob disease are initially misdiagnosed, with most not receiving a correct diagnosis until they are two-thirds of the way through their disease course, show findings in the Archives of Neurology.

27 Sep 2012

Study looks at rapid-onset dystonia-parkinsonism that has no known treatment

Fewer than 100 people in the world are known to be affected by a movement disorder called rapid-onset dystonia-parkinsonism (RDP), but its symptoms are life-changing. Seemingly normal young people are suddenly and dramatically unable to control movement of their arms or legs and have trouble speaking or swallowing. A normal life is nearly impossible.

27 Sep 2012

Pfizer, Bristol-Myers Squibb report FDA acknowledgement of ELIQUIS NDA resubmission

Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the New Drug Application (NDA) resubmission for ELIQUIS (apixaban) to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (NVAF).

27 Sep 2012

Tight-junction proteins could help pin down hemorrhagic transformation risk

Study findings suggest that measuring levels of tight-junction proteins in the blood of patients with stroke may help to gauge their risk for hemorrhagic transformation.

26 Sep 2012

Short-course amphotericin is cost-effective for cryptococcal meningitis

The treatment of cryptococcal meningitis in resource-limited settings is most effective with a short 1-week course of amphotericin induction therapy coupled with high-dose fluconazole for at least 2 weeks, a Ugandan study suggests.

26 Sep 2012

Researchers identify mechanism that appears to underlie non-familial form of Parkinson's

Researchers in the Taub Institute at Columbia University Medical Center (CUMC) have identified a mechanism that appears to underlie the common sporadic (non-familial) form of Parkinson's disease, the progressive movement disorder.

26 Sep 2012

Dual cigarette and waterpipe users more likely to develop dependence, tobacco-related diseases

People who smoke both cigarettes and waterpipes - dual users - lack sufficient knowledge about the risks of tobacco smoking and are at considerable risk for dependence and tobacco-related diseases, such as cancer, heart disease and stroke later in life, according to findings of a new study by Virginia Commonwealth University.

26 Sep 2012

Study: 42% of patients with advanced non-malignant conditions prefer home death

Improved home care resources for people with conditions such as dementia, who would prefer to die at home, are key to providing better end of life care and reducing the strain of the UK's ageing population on the NHS, according to researchers at King's College London.

26 Sep 2012

Warfarin therapy should not be stopped completely after GI bleeding

The decision to not resume warfarin therapy following a gastrointestinal bleeding event is linked to an increased risk for thrombosis and mortality, researchers suggest.

25 Sep 2012

Study uses white matter to study brain function

Most people equate "gray matter" with the brain and its higher functions, such as sensation and perception, but this is only one part of the anatomical puzzle inside our heads. Another cerebral component is the white matter, which makes up about half the brain by volume and serves as the communications network.

25 Sep 2012

Lonafarnib proves effective for children with progeria

Results of the first-ever clinical drug trial for children with Progeria, a rare, fatal "rapid-aging" disease, demonstrate the efficacy of a farnesyltransferase inhibitor (FTI), a drug originally developed to treat cancer. The clinical trial results, completed only six years after scientists identified the cause of Progeria, included significant improvements in weight gain, bone structure and, most importantly, the cardiovascular system, according to The Progeria Research Foundation (PRF) and Boston Children's Hospital.

25 Sep 2012

PPI use linked with risk for infection in decompensated cirrhosis

Proton-pump inhibitors are associated with an increased risk for serious infections in patients with decompensated cirrhosis, research shows.

24 Sep 2012

Confusion reigns on best handover of patients from secondary to primary care

Several planned interventions have reportedly improved the quality and safety of patient handovers between hospital and primary care, yet robust evidence of their benefits is still lacking, conclude researchers who conducted a systematic review of studies to date.

24 Sep 2012

No time to lose in basilar artery occlusion treatment

Patients with basilar artery occlusion should undergo recanalization therapy as soon as possible, show data from BASICS.

24 Sep 2012

Siemens perioperative management solution by SIS for Wentworth-Douglass Hospital

Surgical Information Systems, a leader in perioperative information systems, announced today that Wentworth-Douglass Hospital has selected Siemens perioperative management solution by SIS to replace its legacy perioperative IT system and automate its anesthesia documentation.

From Siemens Healthineers 24 Sep 2012